Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Buy Fulton Financial Corp (FULT)?

Page 1 of 2

Is Fulton Financial Corp (NASDAQ:FULT) a good investment?

In the financial world, there are tons of indicators market participants can use to watch Mr. Market. A duo of the most useful are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the elite hedge fund managers can trounce the market by a significant margin (see just how much).

Just as key, bullish insider trading sentiment is a second way to analyze the financial markets. Just as you’d expect, there are many reasons for a bullish insider to sell shares of his or her company, but only one, very obvious reason why they would behave bullishly. Plenty of empirical studies have demonstrated the valuable potential of this strategy if you understand what to do (learn more here).

Thus, let’s analyze the newest info for Fulton Financial Corp (NASDAQ:FULT).

What does the smart money think about Fulton Financial Corp (NASDAQ:FULT)?

At the end of the second quarter, a total of 9 of the hedge funds we track held long positions in this stock, a change of 13% from the first quarter. With the smart money’s positions undergoing their usual ebb and flow, there exists a few key hedge fund managers who were boosting their stakes meaningfully.

Fulton Financial Corp (NASDAQ:FULT)Out of the hedge funds we follow, Dreman Value Management, managed by David Dreman, holds the biggest position in Fulton Financial Corp (NASDAQ:FULT). Dreman Value Management has a $35.7 million position in the stock, comprising 1.1% of its 13F portfolio. Coming in second is Cliff Asness of AQR Capital Management, with a $7.6 million position; less than 0.1%% of its 13F portfolio is allocated to the company. Some other hedgies that are bullish include Ken Griffin’s Citadel Investment Group, Jacob Gottlieb’s Visium Asset Management and Tom Russo’s Gardner Russo & Gardner.

As industrywide interest increased, certain bigger names were breaking ground themselves. Dreman Value Management, managed by David Dreman, initiated the most outsized position in Fulton Financial Corp (NASDAQ:FULT). Dreman Value Management had 35.7 million invested in the company at the end of the quarter. Cliff Asness’s AQR Capital Management also initiated a $7.6 million position during the quarter. The following funds were also among the new FULT investors: Ken Griffin’s Citadel Investment Group, Jacob Gottlieb’s Visium Asset Management, and Tom Russo’s Gardner Russo & Gardner.

What do corporate executives and insiders think about Fulton Financial Corp (NASDAQ:FULT)?

Insider buying is most useful when the company in question has seen transactions within the past half-year. Over the last half-year time frame, Fulton Financial Corp (NASDAQ:FULT) has seen zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll also take a look at the relationship between both of these indicators in other stocks similar to Fulton Financial Corp (NASDAQ:FULT). These stocks are Signature Bank (NASDAQ:SBNY), National Penn Bancshares (NASDAQ:NPBC), Valley National Bancorp (NYSE:VLY), Webster Financial Corporation (NYSE:WBS), and Susquehanna Bancshares Inc (NASDAQ:SUSQ). All of these stocks are in the regional – northeast banks industry and their market caps resemble FULT’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!